Approval · Notice of Compliance 2066 · 1999
TARKA: Notice of Compliance 2066
Issued October 1, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2066
- Date
- October 1, 1999
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Two new strengths
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- VERAPAMIL HCL 240 MG per TAB
- TRANDOLAPRIL 1 MG per TAB
- TRANDOLAPRIL 2 MG per TAB